Elevated levels of CCL26, both in CSF and blood serum, have been observed in numerous diseases, including Alzheimer’s disease [14], asthma [15], rheumatoid arthritis [16], cancer [17], and experimental autoimmune encephalomyelitis [18]. This evidence concerns the gene CCL26 and rheumatoid arthritis.